| UniProt ID | GGA1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UJY5 | |
| Protein Name | ADP-ribosylation factor-binding protein GGA1 | |
| Gene Name | GGA1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 639 | |
| Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein. Endosome membrane Peripheral membrane protein. |
|
| Protein Description | Plays a role in protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes. Mediates the ARF-dependent recruitment of clathrin to the TGN and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (AC-LL) motif.. | |
| Protein Sequence | MEPAMEPETLEARINRATNPLNKELDWASINGFCEQLNEDFEGPPLATRLLAHKIQSPQEWEAIQALTVLETCMKSCGKRFHDEVGKFRFLNELIKVVSPKYLGSRTSEKVKNKILELLYSWTVGLPEEVKIAEAYQMLKKQGIVKSDPKLPDDTTFPLPPPRPKNVIFEDEEKSKMLARLLKSSHPEDLRAANKLIKEMVQEDQKRMEKISKRVNAIEEVNNNVKLLTEMVMSHSQGGAAAGSSEDLMKELYQRCERMRPTLFRLASDTEDNDEALAEILQANDNLTQVINLYKQLVRGEEVNGDATAGSIPGSTSALLDLSGLDLPPAGTTYPAMPTRPGEQASPEQPSASVSLLDDELMSLGLSDPTPPSGPSLDGTGWNSFQSSDATEPPAPALAQAPSMESRPPAQTSLPASSGLDDLDLLGKTLLQQSLPPESQQVRWEKQQPTPRLTLRDLQNKSSSCSSPSSSATSLLHTVSPEPPRPPQQPVPTELSLASITVPLESIKPSNILPVTVYDQHGFRILFHFARDPLPGRSDVLVVVVSMLSTAPQPIRNIVFQSAVPKVMKVKLQPPSGTELPAFNPIVHPSAITQVLLLANPQKEKVRLRYKLTFTMGDQTYNEMGDVDQFPPPETWGSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEPAMEPE -------CCCCCCHH | 14.54 | 22814378 | |
| 15 | Ubiquitination | ETLEARINRATNPLN HHHHHHHHHHCCCCH | 23.21 | 21963094 | |
| 23 | Ubiquitination | RATNPLNKELDWASI HHCCCCHHCCCHHHH | 68.30 | - | |
| 23 | Ubiquitination | RATNPLNKELDWASI HHCCCCHHCCCHHHH | 68.30 | 23000965 | |
| 28 | Ubiquitination | LNKELDWASINGFCE CHHCCCHHHHHHHHH | 10.53 | 21890473 | |
| 28 | Ubiquitination | LNKELDWASINGFCE CHHCCCHHHHHHHHH | 10.53 | 23000965 | |
| 46 | Ubiquitination | EDFEGPPLATRLLAH CCCCCCHHHHHHHHH | 9.52 | 25015289 | |
| 54 (in isoform 2) | Ubiquitination | - | 36.51 | 21890473 | |
| 54 | Ubiquitination | ATRLLAHKIQSPQEW HHHHHHHHCCCHHHH | 36.51 | - | |
| 57 (in isoform 6) | Phosphorylation | - | 31.83 | 24043423 | |
| 57 (in isoform 5) | Phosphorylation | - | 31.83 | 24043423 | |
| 68 (in isoform 6) | Phosphorylation | - | 26.51 | 24043423 | |
| 68 (in isoform 5) | Phosphorylation | - | 26.51 | 24043423 | |
| 69 | Ubiquitination | EAIQALTVLETCMKS HHHHHHHHHHHHHHH | 4.77 | 24816145 | |
| 73 | Glutathionylation | ALTVLETCMKSCGKR HHHHHHHHHHHCCHH | 2.06 | 22555962 | |
| 88 | Ubiquitination | FHDEVGKFRFLNELI HHHHHHHHHHHHHHH | 5.70 | 23000965 | |
| 92 | Ubiquitination | VGKFRFLNELIKVVS HHHHHHHHHHHHHHC | 39.04 | 21890473 | |
| 92 | Ubiquitination | VGKFRFLNELIKVVS HHHHHHHHHHHHHHC | 39.04 | 22817900 | |
| 93 | Ubiquitination | GKFRFLNELIKVVSP HHHHHHHHHHHHHCH | 54.76 | 21890473 | |
| 96 | Ubiquitination | RFLNELIKVVSPKYL HHHHHHHHHHCHHHC | 49.56 | 23000965 | |
| 99 | Phosphorylation | NELIKVVSPKYLGSR HHHHHHHCHHHCCCC | 20.75 | - | |
| 101 | Ubiquitination | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 23000965 | |
| 101 | Ubiquitination | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 21890473 | |
| 101 (in isoform 1) | Ubiquitination | - | 45.67 | 21890473 | |
| 101 | Malonylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 30639696 | |
| 101 | Malonylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 26320211 | |
| 101 | Acetylation | LIKVVSPKYLGSRTS HHHHHCHHHCCCCCC | 45.67 | 25953088 | |
| 105 | Ubiquitination | VSPKYLGSRTSEKVK HCHHHCCCCCCHHHH | 29.77 | 23000965 | |
| 105 | Phosphorylation | VSPKYLGSRTSEKVK HCHHHCCCCCCHHHH | 29.77 | 22798277 | |
| 108 | Phosphorylation | KYLGSRTSEKVKNKI HHCCCCCCHHHHHHH | 34.02 | 22798277 | |
| 110 | Ubiquitination | LGSRTSEKVKNKILE CCCCCCHHHHHHHHH | 59.27 | 23000965 | |
| 113 | Ubiquitination | RTSEKVKNKILELLY CCCHHHHHHHHHHHH | 39.32 | 23000965 | |
| 118 | Ubiquitination | VKNKILELLYSWTVG HHHHHHHHHHHHHCC | 4.95 | 23000965 | |
| 122 | Ubiquitination | ILELLYSWTVGLPEE HHHHHHHHHCCCCHH | 4.99 | 29967540 | |
| 125 | Ubiquitination | LLYSWTVGLPEEVKI HHHHHHCCCCHHHHH | 28.30 | 32015554 | |
| 132 (in isoform 2) | Ubiquitination | - | 5.17 | 21890473 | |
| 133 | Ubiquitination | LPEEVKIAEAYQMLK CCHHHHHHHHHHHHH | 6.94 | 24816145 | |
| 140 | Acetylation | AEAYQMLKKQGIVKS HHHHHHHHHCCCCCC | 37.39 | 25953088 | |
| 141 | Acetylation | EAYQMLKKQGIVKSD HHHHHHHHCCCCCCC | 50.20 | 25953088 | |
| 141 (in isoform 2) | Ubiquitination | - | 50.20 | 21890473 | |
| 141 | Ubiquitination | EAYQMLKKQGIVKSD HHHHHHHHCCCCCCC | 50.20 | - | |
| 147 | Phosphorylation | KKQGIVKSDPKLPDD HHCCCCCCCCCCCCC | 48.53 | 28348404 | |
| 155 | Phosphorylation | DPKLPDDTTFPLPPP CCCCCCCCCCCCCCC | 37.40 | 28348404 | |
| 156 | Phosphorylation | PKLPDDTTFPLPPPR CCCCCCCCCCCCCCC | 30.19 | 20068231 | |
| 157 | Ubiquitination | KLPDDTTFPLPPPRP CCCCCCCCCCCCCCC | 6.76 | 21890473 | |
| 158 | Ubiquitination | LPDDTTFPLPPPRPK CCCCCCCCCCCCCCC | 41.69 | - | |
| 165 (in isoform 2) | Ubiquitination | - | 66.19 | 21890473 | |
| 165 | Ubiquitination | PLPPPRPKNVIFEDE CCCCCCCCCCCCCCH | 66.19 | 21890473 | |
| 165 | Ubiquitination | PLPPPRPKNVIFEDE CCCCCCCCCCCCCCH | 66.19 | 22817900 | |
| 165 (in isoform 1) | Ubiquitination | - | 66.19 | 21890473 | |
| 174 (in isoform 1) | Ubiquitination | - | 54.02 | 21890473 | |
| 174 | Ubiquitination | VIFEDEEKSKMLARL CCCCCHHHHHHHHHH | 54.02 | 21906983 | |
| 175 | Ubiquitination | IFEDEEKSKMLARLL CCCCHHHHHHHHHHH | 26.95 | 25015289 | |
| 182 | Ubiquitination | SKMLARLLKSSHPED HHHHHHHHHCCCHHH | 4.16 | 22817900 | |
| 183 | Ubiquitination | KMLARLLKSSHPEDL HHHHHHHHCCCHHHH | 55.28 | 33845483 | |
| 183 | Methylation | KMLARLLKSSHPEDL HHHHHHHHCCCHHHH | 55.28 | - | |
| 184 | Phosphorylation | MLARLLKSSHPEDLR HHHHHHHCCCHHHHH | 33.57 | 30108239 | |
| 185 | Phosphorylation | LARLLKSSHPEDLRA HHHHHHCCCHHHHHH | 41.28 | 30108239 | |
| 191 | Ubiquitination | SSHPEDLRAANKLIK CCCHHHHHHHHHHHH | 43.93 | 33845483 | |
| 191 | Ubiquitination | SSHPEDLRAANKLIK CCCHHHHHHHHHHHH | 43.93 | 21890473 | |
| 192 | Ubiquitination | SHPEDLRAANKLIKE CCHHHHHHHHHHHHH | 23.76 | 25015289 | |
| 195 | Acetylation | EDLRAANKLIKEMVQ HHHHHHHHHHHHHHH | 47.03 | 25953088 | |
| 195 | Ubiquitination | EDLRAANKLIKEMVQ HHHHHHHHHHHHHHH | 47.03 | 29967540 | |
| 198 | Ubiquitination | RAANKLIKEMVQEDQ HHHHHHHHHHHHHHH | 50.63 | 33845483 | |
| 198 (in isoform 1) | Ubiquitination | - | 50.63 | 21890473 | |
| 200 | Ubiquitination | ANKLIKEMVQEDQKR HHHHHHHHHHHHHHH | 2.99 | 33845483 | |
| 200 | Ubiquitination | ANKLIKEMVQEDQKR HHHHHHHHHHHHHHH | 2.99 | - | |
| 206 | Ubiquitination | EMVQEDQKRMEKISK HHHHHHHHHHHHHHH | 67.06 | 24816145 | |
| 215 | Ubiquitination | MEKISKRVNAIEEVN HHHHHHHHHHHHHHH | 6.97 | 21890473 | |
| 215 | Ubiquitination | MEKISKRVNAIEEVN HHHHHHHHHHHHHHH | 6.97 | 33845483 | |
| 223 | Ubiquitination | NAIEEVNNNVKLLTE HHHHHHHHHHHHHHH | 60.90 | 24816145 | |
| 223 | Ubiquitination | NAIEEVNNNVKLLTE HHHHHHHHHHHHHHH | 60.90 | - | |
| 236 | Phosphorylation | TEMVMSHSQGGAAAG HHHHHHCCCCCCCCC | 24.18 | 17525332 | |
| 244 | Phosphorylation | QGGAAAGSSEDLMKE CCCCCCCCHHHHHHH | 26.31 | 28348404 | |
| 245 | Phosphorylation | GGAAAGSSEDLMKEL CCCCCCCHHHHHHHH | 33.92 | 28348404 | |
| 262 | Phosphorylation | RCERMRPTLFRLASD HHHHHCHHHHHHHCC | 28.32 | - | |
| 268 | Phosphorylation | PTLFRLASDTEDNDE HHHHHHHCCCCCCHH | 50.05 | 28348404 | |
| 270 | Phosphorylation | LFRLASDTEDNDEAL HHHHHCCCCCCHHHH | 42.62 | 27273156 | |
| 355 | Phosphorylation | EQPSASVSLLDDELM CCCCCEEEECCHHHH | 22.25 | 12060753 | |
| 359 | Ubiquitination | ASVSLLDDELMSLGL CEEEECCHHHHHCCC | 51.39 | 29967540 | |
| 373 | Ubiquitination | LSDPTPPSGPSLDGT CCCCCCCCCCCCCCC | 65.62 | 29967540 | |
| 412 | Phosphorylation | ESRPPAQTSLPASSG CCCCCCCCCCCCCCC | 34.05 | 24275569 | |
| 418 | Phosphorylation | QTSLPASSGLDDLDL CCCCCCCCCCCHHHH | 45.54 | 14702039 | |
| 434 | Phosphorylation | GKTLLQQSLPPESQQ HHHHHHHCCCHHHHH | 29.86 | 28857561 | |
| 446 | Ubiquitination | SQQVRWEKQQPTPRL HHHCHHHHCCCCCCE | 47.47 | 29967540 | |
| 450 | Phosphorylation | RWEKQQPTPRLTLRD HHHHCCCCCCEEHHH | 19.39 | - | |
| 463 | Ubiquitination | RDLQNKSSSCSSPSS HHHCCCCCCCCCCCH | 36.65 | - | |
| 478 | Phosphorylation | SATSLLHTVSPEPPR HHHHHHHHCCCCCCC | 23.73 | 26074081 | |
| 480 | Phosphorylation | TSLLHTVSPEPPRPP HHHHHHCCCCCCCCC | 25.38 | 26074081 | |
| 493 | Phosphorylation | PPQQPVPTELSLASI CCCCCCCCEEEEEEE | 50.20 | 30243723 | |
| 496 | Phosphorylation | QPVPTELSLASITVP CCCCCEEEEEEEEEE | 18.69 | 30243723 | |
| 499 | Phosphorylation | PTELSLASITVPLES CCEEEEEEEEEEHHH | 24.88 | 30243723 | |
| 501 | Phosphorylation | ELSLASITVPLESIK EEEEEEEEEEHHHCC | 17.36 | 30243723 | |
| 506 | Phosphorylation | SITVPLESIKPSNIL EEEEEHHHCCHHHEE | 43.53 | 30243723 | |
| 546 | Phosphorylation | DVLVVVVSMLSTAPQ CEEEEEEECCCCCCC | 11.46 | 19276368 | |
| 550 | Phosphorylation | VVVSMLSTAPQPIRN EEEECCCCCCCCHHH | 38.09 | 19276368 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 355 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 355 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GGA1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GGA1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY. | |